Biomedtech Portfolio

Vexim

Minimally invasive spinal implant

Focusing on transforming vertebral fracture treatment, Vexim developed a minimally invasive surgical implant that is appproved in both the US and Europe. The company was sold in 2017 to Stryker for $221 million.

LATEST NEWS

September 20, 2018

Vincent Gardès, former CEO of VEXIM, joins Truffle Capital

OTHER COMPANIES

Symetis

Minimaly invasive Aortic Valve

Carmat

First-of its kind implantable artificial heart

Evexta Bio

Developing Next Generation Precision Cancer Therapies

Spikimm

SpikImm develops long-acting mAbs to prevent viral infections in imunocompromized patients, in pa...

PK Med

Locally administered therapeutic products to address inflammatory joint diseases and tissue regen...

Skinosive

Bio-adhesive UV filters for long lasting and broad-spectrum sun protection

Caranx Medical

Autonomous robot improving efficiency and safety in Transcatheter Aortic Valve Replacement (TAVI...

BariaTek

Minimally invasive, atraumatic, reversible and endoscopically delivered medical device to treat o...

Artedrone

Autonomous robotic solution to increase the accessibility of mechanical thrombectomy during acute...

Carbios

Biotechnology powering plastic and textile circularity